Abu Dhabi-based digital healthcare startup Alma Health has confirmed that it recently received funding from the Hambro Perks Oryx Fund, a venture fund focused almost exclusively on early-stage startups in MENA.
The net yield from the round was not disclosed by either party, however it is believed to be a sizable amount — especially considering that Strategic Angels from the UAE and Saudi also chipped in with significant amounts.
Khaldoon Bushnaq, former Head of Strategy for Careem, and Tariq Seksek, former Head of Product for Dubizzle banded together to launch Alma Health in late 2020. The platform it offers is aimed at building and enhancing a patient-centric healthcare system for approximately 20 million residents of GCC.
The startup thrives to offer a comprehensive and end-to-end healthcare experience including doctor consultation, medicine home delivery, quality options for patients who want to receive their treatment from the comfort of home, and so on.
Currently operating out of its headquarter in Hub71, Alma Health is so far available in Abu Dhabi. It is fully licensed by the Emirate’s Department of Health and is accredited by major health insurance companies.
“We are pleased to be partnering with the Oryx Fund to support our expansion and growth. In addition to being dedicated regional investors, the team has a wealth of experience in digital healthcare, having previously backed leading international businesses in this sector,” said Khaldoon Bushnaq, co-founder of Alma Health.
“We are on a clear mission to become the leading digital platform for chronic condition management by harnessing technology to transform lives in our region. This investment will enable us to achieve these goals sooner.”
With the newly raised capital, the startup finds itself in a far better spot to aggressively pursue its global expansion roadmap starting with the planned expansion into Saudi Arabia towards late-2021.